PRESS RELEASE
News
-
-
-
PRESS RELEASE
Theranexus, Diverchim et l'INSERM bénéficient d'un financement de 4.7 millions d'euros dans le cadre de l'appel à projets " Innovations en Biothérapies et Bioproduction " de France 2030, pour développer un nouvel oligonucléotide antisens
Theranexus, Diverchim, and ARNA laboratory of INSERM receive 4.7 million euros from the French government to develop a groundbreaking autophagy activation therapy called PickASO -
PRESS RELEASE
Theranexus, Diverchim and Inserm awarded EUR 4.7 million in funding under the "Innovations in biotherapies and biomanufacturing" call for proposals from France 2030 to develop a novel antisense oligonucleotide
Theranexus, Diverchim, and Inserm's ARNA laboratory receive €4.7 million funding from French Government to develop autophagy activation therapy for rare neurological diseases under the PickASO project in collaboration with France 2030 -
-
REGULATED PRESS RELEASE
Covivio - Signing of a strategic partnership in Germany Residential with CDC investissement immobilier
CDC Investissement Immobilier and Covivio announce strategic partnership in Germany for residential portfolio in Berlin, with CDC acquiring 49% stake. Partnership highlights Covivio's quality assets and Covivio's plans for environmental improvements by 2030 -
-
REGULATED PRESS RELEASE
OVHcloud - OVHcloud annonce la nomination de Benjamin Revcolevschi comme Directeur Général Adjoint du Groupe
OVHcloud annonce la nomination de Benjamin Revcolevschi comme Directeur Général Adjoint du Groupe et son intégration au comité exécutif dès le 6 mai 2024. Benjamin apportera son expertise pour le développement et l'innovation -
-
